An acyclic nucleoside phosphonate effectively blocks the egress of the malaria parasite by inhibiting the synthesis of cyclic GMP
Science Advances · 2025
DOI: 10.1126/sciadv.ady2859 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Marie Ali und 13 weiteren Autor:innen. Beteiligte Einrichtung: LPHI, University of Montpellier, CNRS, Inserm, 34095 Montpellier, France. Hauptthemen laut MEDLINE: Plasmodium falciparum, Cyclic GMP, Antimalarials, Organophosphonates. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Agence Nationale de la Recherche, French Infrastructure for Integrated Structural Biology, France Génomique National infrastructure.
Abstract (Originalsprache)
The urgent need for original antimalarial therapies arises from the alarming spread of malaria parasite resistance to existing drugs. A promising candidate, UA2239, an acyclic nucleoside phosphonate with a guanine as nucleobase, demonstrates rapid and irreversible inhibitory effects on Plasmodium parasites. It blocks the active exit process, named egress, of merozoites and gametes from infected erythrocytes. UA2239 disrupts the essential cyclic guanosine monophosphate (cGMP)–dependent egress pathway by decreasing cGMP levels in the parasite, strongly suggesting Plasmodium falciparum guanylyl cyclase α as its primary target. We also uncovered remarkable molecular mechanisms of resistance developed by parasites after prolonged exposure to the drug, which involve mutating not the target itself, but downstream effectors. The unique mechanism of action of UA2239 makes it a valuable first-in-class candidate for further development. Its ability to inhibit both parasite growth and transmission highlights its therapeutic potential as a dual-stage antimalarial agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- LPHI, University of Montpellier, CNRS, Inserm, 34095 Montpellier, France.
- Institut Cochin, Université Paris Cité, CNRS, Inserm, 75014 Paris, France.
- IBMM, University of Montpellier, CNRS, ENSCM, 34293 Montpellier, France.
- CBS, University of Montpellier, CNRS, INSERM, 34090 Montpellier, France.
ORCID-Profile: Marie Ali, Rea Dura, Marc-Antoine Guery, Emma Colard-Itté, Thomas Cheviet, Léa Robresco, Laurence Berry, Corinne Lionne, Catherine Lavazec, Antoine Claessens, Suzanne Peyrottes, Kai Wengelnik, Sharon Wein, Rachel Cerdan
Förderung
- Agence Nationale de la Recherche
- French Infrastructure for Integrated Structural Biology
- France Génomique National infrastructure
- Fondation Méditerranée Infection
Zitieren
APA
Ali, M., Dura, R., Guery, M. A., Colard-Itté, E., Cheviet, T., Robresco, L., Berry, L., Lionne, C., Lavazec, C., Claessens, A., Peyrottes, S., Wengelnik, K., Wein, S., & Cerdan, R. (2025). An acyclic nucleoside phosphonate effectively blocks the egress of the malaria parasite by inhibiting the synthesis of cyclic GMP. Science Advances. https://doi.org/10.1126/sciadv.ady2859
Vancouver
Ali M, Dura R, Guery MA, Colard-Itté E, Cheviet T, Robresco L, et al. An acyclic nucleoside phosphonate effectively blocks the egress of the malaria parasite by inhibiting the synthesis of cyclic GMP. Science Advances. 2025. doi:10.1126/sciadv.ady2859
BibTeX
@article{Ali2025,
author = {Ali, Marie and Dura, Rea and Guery, Marc-Antoine and Colard-Itté, Emma and Cheviet, Thomas and Robresco, Léa and Berry, Laurence and Lionne, Corinne and Lavazec, Catherine and Claessens, Antoine and Peyrottes, Suzanne and Wengelnik, Kai and Wein, Sharon and Cerdan, Rachel},
title = {An acyclic nucleoside phosphonate effectively blocks the egress of the malaria parasite by inhibiting the synthesis of cyclic GMP},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.ady2859}
}
EUVIMED